JetBlue Airways Corporation vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? JetBlue Airways Corporation trades at $3.91 (market cap $1.50B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.34 (market cap $2.28B). The key difference: SELLAS Life Sciences Group Inc. Common Stock is the larger of the two by market cap, and SELLAS Life Sciences Group Inc. Common Stock is trading nearer its 52-week high, JetBlue Airways Corporation nearer its low. Which is the better fit depends on your goals.
| JBLU | SLS | |
|---|---|---|
Market Cap | $1.50B | $2.28B |
Volume | 22,018,927 | 3,128,960 |
Sector | Industrials | Health |
52-Week High | $6.46 | $15.46 |
52-Week Low | $3.92 | $1.39 |
Typical Hold Time | 44 Days | — |
Enterprise Value | $8.86B | $2.15B |
Signals from Pluang's Aura AI — not financial advice
JetBlue (JBLU) trades at $3.92, down 2.73% on the day, reflecting ongoing challenges. The stock shows a bearish technical trend with key indicators mixed, while fundamentals reveal persistent losses with a negative net income margin of -9.32% and elevated debt levels. Recent news includes route expansion to Colombia but also capacity cuts due to fuel costs, highlighting operational pressures amid a difficult industry environment.
The outlook remains cautious with high debt and consistent earnings misses posing significant risks. However, the consensus price target of $5.89 suggests potential upside if operational improvements materialize. Investors face headwinds from fuel price volatility and competitive pressures, requiring careful monitoring of cost management and travel demand recovery for any sustained rebound.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It carries over millions of customers with an average of more than 1,000 daily flights and served approximately 99 destinations in the United States, the Caribbean, and Latin America. The company currently operates Airbus A321, Airbus A320, and Embraer E190 aircraft types.
Read more on JBLU →SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →